Document is current
Any future updates will be listed below
-
Authors
Ma, Qiu-Lan
Ebright, Brandon
Li, Boyang
Li, Jing
Galvan, Jasmin
Sanchez, Ashley
Renteln, Michael
Dikeman, Dante
Wang, Shaowei
Kerman, Bilal E.
Wang, Xinhui
Manvelian, Marina
Yu, Xiaohui
Seidler, Paul
Gutierrez-Grebenkova, Berenice
Hjelm, Brooke E.
Hawes, Debra
Hiniker, Anne E.
Hurth, Kyle M.
Bennett, David A.
Louie, Stan G.
Chui, Helena C.
Limon, Agenor
Arvanitakis, Zoe
Yassine, Hussein N.
-
Funding
Funding for this research was provided by:
National Institute on Aging (P30AG066530)
National Institute on Aging (R01AG070255)
National Institute on Aging (R01AG082362)
- License Information
-
More Information
Article History
Received: 16 December 2025
Accepted: 21 December 2025
First Online: 12 February 2026
Declarations
:
: The use of human postmortem brain tissues and sections in this study were approved by an Institutional Review Board (IRB) of Rush University Medical Center and the University of Southern California (HS-24-00457), and informed consent was obtained.
: All authors read and approved the final manuscript.
: Informed consent was obtained in accordance with the Declaration of Helsinki.
: HNY is founder of PebRx that is developing cPLA2 inhibitors.
